Can Cannabis Help Slow Alzheimer’s Disease? A Recent Study Says It Might – Food & Wine
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchCBDNeurologyAgingSafetyMental HealthAnxiety Why This Matters Clinicians caring for Alzheimer’s patients…
Avicanna Announces Closing of Non-Brokered Private Placement | Markets Insider
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBDTHCSafetyPolicyPain Clinical Summary Avicanna has completed a non-brokered private placement to fund…
Opinion: Cannabis, medicine and the crisis of public trust – Anchorage Daily News
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchSafetyMental HealthPainAnxietyCBD Clinical Summary This opinion piece addresses the erosion of public…
Why Pharma Is Taking Cannabis Seriously – The Dales Report
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchPolicyIndustryPainMental HealthCBDTHC Clinical Summary # Clinical Summary The pharmaceutical industry’s…
Identification of cannabichromevarin as a potent stabilizer of the measles virus prefusion F protein
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyNeurologyMental HealthCBDHempIndustry Why This Matters This research identifying cannabichromevarin (CBCV)…
NIST Expands Mass Spectrometry Library to Improve Chemical Identification – Lab Manager
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchSafetyIndustryHempCBDTHCPain Why This Matters Clinicians need reliable analytical standards to distinguish…
Week in Weed – June 13, 2026 – StratCann
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchIndustryCBDTHCSafetyPolicyHemp Clinical Summary # Clinical Summary This article highlights advances in cannabis…
The United States just offically recliassified cannabis. The federal reclassification of medical …
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchTHCCBDIndustryDosingSafety Why This Matters Federal reclassification of cannabis from Schedule I to…
ASX Cannabis Stocks 2026: Why Proof Matters More Than Hype | Kalkine Media
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PolicyResearchIndustrySafetyDosingCBDTHC Why This Matters Cannabis companies’ financial viability and…
ZYUS Life Sciences announces strategic realignment | The Pharmaletter
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. PainResearchIndustryCBDTHCSafetyNeurology Why This Matters Clinicians treating chronic back pain patients need…